The Discounted Cash Flow (DCF) valuation of Pacific Biosciences of California Inc (PACB) is (21.51) USD. With the latest stock price at 1.03 USD, the upside of Pacific Biosciences of California Inc based on DCF is -2178.6%.
Based on the latest price of 1.03 USD and our DCF valuation, Pacific Biosciences of California Inc (PACB) is a sell. selling PACB stocks now will result in a potential gain of 2178.6%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 7.6% - 9.0% | 8.3% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (33.59) - (16.27) | (21.51) |
| Upside | -3345.3% - -1671.8% | -2178.6% |